Stockreport

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Net sales of DARZALEX® in the third quarter of 2024 totaled USD 3,016 millionGenmab receives royalties on worldwide net sales from Janssen Biotec [Read more]